Literature DB >> 29393393

RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.

Lei Wang1, Zhichao Hou1, Ayshamgul Hasim2, Abulajiang Abuduerheman1, Haiping Zhang1, Madiniyat Niyaz3, Idiris Awut1, Halmurat Upur4, Ilyar Sheyhidin1.   

Abstract

Ring finger protein 113A (RNF113A) possesses a C3HC4 zinc finger domain and this domain is found in E3 ubiquitin ligase and is involved in tumorigenesis. To date, and at least to the best of our knowledge, there are no studies available which have investigated RNF113A in cancer. Thus, this study aimed to explore the role of RNF113A in the development of esophageal squamous cell carcinoma (ESCC). For this purpose, paraffin-embedded samples from 117 patients with ESCC were selected, as well as 41 pairs of fresh-frozen ESCC and adjacent normal tissue samples. RNF113A expression was examined by immunohistochemistry and reverse transcription-quantitative PCR (RT-qPCR). RNF113A was overexpressed or silenced in the EC9706 and Eca109 cells. The cells were examined for cell cycle progression, apoptosis, invasiveness and migration. Xenograft tumors were also created in mice using the Eca109 cells. Tumor differentiation (P=0.008) and T classification (P<0.001) were found to be significantly associated with RNF113A expression. No statistically significant association was observed between RNF113A expression and sex, age, histological type, tumor location and lymph node metastasis (N classification). Kaplan-Meier analysis revealed that the patients with ESCC with ahigh expression of RNF113A had a lower survival rate than those with a low expression (P=0.002). Multivariate analysis revealed that RNF113A expression (HR=2.406; 95% CI, 1.301-4.449, P=0.005) was independently associated with overall survival in patients with ESCC. The overexpression of RNF113A promoted proliferation, migration, and invasiveness of ESCC cell lines in vitro, and RNF113A silencing reversed these malignant behaviors. RNF113A knockdown inhibited tumor growth in vivo. Thus, these results indicate that RNF113A promotes the proliferation, migration and invasiveness of ESCC cell lines. RNF113A expression in ESCC is this associated with a poor prognosis of affected patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29393393     DOI: 10.3892/ijo.2018.4253

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer.

Authors:  Qiang Guo; Si-Hua Wang; Yan-Mei Ji; Song Tong; Dan Li; Xiang-Chao Ding; Chuang-Yan Wu
Journal:  Curr Med Sci       Date:  2022-10-03

2.  Downregulation of long non-coding RNA LOC101928477 correlates with tumor progression by regulating the epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Demiao Kong; Dali Long; Bo Liu; Dengke Pei; Na Cao; Guihua Zhang; Zhenkun Xia; Meng Luo
Journal:  Thorac Cancer       Date:  2021-03-13       Impact factor: 3.500

Review 3.  Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.

Authors:  Nair Lopes; Margareta P Correia; Rui Henrique; Carmen Jerónimo
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

4.  Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

Authors:  Jian Wang; Sana Sahengbieke; Xiaoping Xu; Lei Zhang; Xiaoming Xu; Lifeng Sun; Qun Deng; Da Wang; Dong Chen; Yuan Pan; Zhaohui Liu; Shaojun Yu
Journal:  Onco Targets Ther       Date:  2018-10-18       Impact factor: 4.147

5.  Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer.

Authors:  Xiao Wang; Tianzuo Li
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 6.  Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling.

Authors:  Anmol Sharma; Heena Khan; Thakur Gurjeet Singh; Amarjot Kaur Grewal; Agnieszka Najda; Małgorzata Kawecka-Radomska; Mohamed Kamel; Ahmed E Altyar; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.